Release of Prostaglandin D2 into Human Airways during Acute Antigen Challenge

JJ Murray, AB Tonnel, AR Brash… - … England Journal of …, 1986 - Mass Medical Soc
JJ Murray, AB Tonnel, AR Brash, LJ Roberts, P Gosset, R Workman, A Capron, JA Oates
New England Journal of Medicine, 1986Mass Medical Soc
Among the many possible mediators of the early asthmatic response, prostaglandin D2, a
bronchoconstrictor, is the principal cyclooxygenase metabolite of arachidonic acid that is
released upon the activation of mast cells and is also synthesized by human alveolar
macrophages. We performed bronchoalveolar lavage in five patients with chronic stable
asthma, before and up to nine minutes after local provocative challenge with
Dermatophagoides pteronyssinus. The lavage fluid was analyzed for products of …
Abstract
Among the many possible mediators of the early asthmatic response, prostaglandin D2, a bronchoconstrictor, is the principal cyclooxygenase metabolite of arachidonic acid that is released upon the activation of mast cells and is also synthesized by human alveolar macrophages. We performed bronchoalveolar lavage in five patients with chronic stable asthma, before and up to nine minutes after local provocative challenge with Dermatophagoides pteronyssinus. The lavage fluid was analyzed for products of arachidonic acid metabolism. Prostaglandin D2 levels in all five patients rose an average of 150-fold, from <8 to 332±114 pg per milliliter (mean ±SEM; P<0.050), after local instillation of the antigen. Levels of 15-hydroxyeicosatetraenoic acid, which may also have a role in the pulmonary allergic response, were detectable in lavage fluid before challenge and increased after provocation with the antigen in four of the five patients. The activity of β-glucuronidase, an enzyme released by macrophages and mast cells upon stimulation, tended to increase in the lavage fluid after provocation in all patients.
These studies provide evidence that the release of prostaglandin D2 into the airways is an early event after the instillation of D. pteronyssinus in patients who are sensitive to this antigen. (N Engl J Med 1986; 315:800–4.)
The New England Journal Of Medicine